Every year, hurricanes destroy lives, striking some of our Nations most beautiful regions and leaving devastation in their wake. National Hurricane Preparedness Week is a time to raise awareness about the dangers of these storms and encourage citizens in coastal areas and inland communities to be vigilant in emergency planning and preparation.
Hurricanes, storm surges, and flooding can wash away homes and properties, but the greatest threat is the loss of life, making readiness paramount. Those living in at-risk areas should have a family evacuation plan and a supply of non-perishable food, water, medicine, batteries, and other essential items.
This August marks the 20th anniversary of Hurricane Katrina, which caused widespread destruction and loss of life, leaving an indelible impact on the Louisiana Delta and Mississippi Coast. Tragically, in the decades since, other catastrophic hurricanes most recently Helene and Milton have devastated communities and shattered lives throughout our Nation.
In the aftermath of each storm, the intrepid American spirit emerged. It was evident in the professionalism and compassion of volunteers and organizations offering aid, comfort, and temporary shelter and in the extraordinary resilience and strength of those left to rebuild their lives. I witnessed this firsthand in North Carolina after Hurricane Helene, where I met with survivors and local leaders working tirelessly to restore their communities.
I remain steadfastly committed to supporting hurricane recovery efforts and ensuring that Federal resources and tax dollars are allocated to American citizens in need. I signed an Executive Order giving State and local authorities a more significant role in resilience, preparedness, and rapid-response efforts. Local officials have the insight to make risk-informed decisions, deploy resources, manage operations, and eliminate ineffective bureaucracy so we can better serve affected communities.
As hurricane season approaches, I urge every household to recognize the dangers of severe weather, assess their risk, and develop a comprehensive plan to ensure disaster preparedness.
NOW, THEREFORE, I, DONALD J. TRUMP, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim May 4 through May 10, 2025, as National Hurricane Preparedness Week. I call upon Americans living in hurricane-prone areas to safeguard their families, homes, and businesses from the dangers of hurricanes.
Small businesses power our economy from the ground up, driving innovation and building products that keep America strong, competitive, and secure. During National Small Business Week, we celebrate the unyielding spirit, creativity, and perseverance of our hardworking entrepreneurs who dare to dream big.
Small businesses are vital to our economy. America has 33 million small businesses that employ 61.7 million Americans nearly half of the private-sector workforce and create almost two out of every three new jobs in the country.
In recent years, small business owners have faced unprecedented challenges record high inflation, reckless Federal spending, and burdensome regulations yet have remained committed to delivering for Americas communities.
Small businesses across the country have also carried the burden of a broken global trade system for far too long. Originally designed after World War II to support recovery in war-torn nations, it is now exploited by foreign competitors. They flood our markets with cheap goods while shutting out quality American products.
Too many in our Government were afraid to tackle this problem. Now, at last, my Administration is fixing it. On Liberation Day, we implemented targeted tariffs to protect American businesses from unfair trade practices and to strengthen local supply chains. We are putting American people first and delivering long-overdue relief for our workers and entrepreneurs.
My Administration is unleashing a new era of opportunity for small businesses built on common sense and pro-growth policies that put our workers and our job creators first. We are cutting red tape, keeping taxes low, promoting fair and reciprocal trade practices, and fighting for hardworking Americans.
The Made in America Manufacturing Initiative is creating good-paying jobs and securing our supply chains, while cutting $100 billion in regulations that disproportionately burden small businesses and manufacturers. Free from crippling compliance and regulatory hurdles, we are empowering our businesses to focus on what they do best: business.
Entrepreneurship is the foundation of a free and prosperous Nation and the engine of the American economy built by men and women who work hard, take risks, and believe in the power of the American Dream. From our fields to our factories to the frontiers of technology, our small businesses embody the American spirit, driving growth and creating new employment opportunities. Our history of ingenuity and grit is unrivaled, and by renewing our support of small businesses, we are raising wages, strengthening American families, and leading our country and the world into a new Golden Age.
NOW, THEREFORE, I, DONALD J. TRUMP, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim May 4 through May 10, 2025, as National Small Business Week. I call upon all Americans to recognize the critical contributions of Americas entrepreneurs and small business owners as they grow our Nations economy.
National Mental Health Awareness Month was founded by Mental Health America in 1949 with the following key objectives:
Educating the public about mental health conditions and their impact.
Reducing stigma by encouraging open conversations and fostering acceptance.
Highlighting the importance of early intervention and access to treatment.
Sharing available mental health resources, including support groups and crisis services.
Building solidarity and reducing isolation for those facing mental health challenges.
Advocating for improved mental health policies, increased funding and better access to care.
Promoting mental wellbeing and self-care practices for overall health.
To honor this yearly tradition, President Trump signed a Proclamation on May 5, 2025 declaring:
During National Mental Health Awareness Month, we recognize the millions of Americans affected by mental health challenges, and my Administration remains committed to prioritizing their well-being.
Mental illnesses can affect anyone, regardless of their background or circumstances. No person should have to face these challenges alone. Recognizing the signs, fostering open dialogue, and showing compassion are essential steps in addressing mental health challenges and supporting those who face them.
My Administration is confronting the mental health challenges facing our Nation as part of the efforts to improve the overall health and well-being of all Americans. The Make America Healthy Again Commission is addressing the root cause of our countrys escalating health crisis and is committed to providing transparency and open-source data, conducting gold-standard research, along with improving access to nutritious food, and expanding treatment options to protect the health of every American.
We also remain committed to making sure every man and woman who served in uniform has access to the mental health care and suicide prevention resources they need. No one who has defended our country should struggle to get support when they need it most.
If you are struggling with your mental health, it is important to reach out to others and seek professionals for support. Together, we will build a stronger, healthier future for all.
NOW, THEREFORE, I, DONALD J. TRUMP, President of the United States of America, by virtue of the authority vested in me by the Constitution and the laws of the United States, do hereby proclaim May 2025 as National Mental Health Awareness Month. I call upon all Americans to support citizens suffering from mental illnesses, raise awareness of mental health conditions through appropriate programs and activities, and commit our Nation to innovative prevention, diagnosis, and treatment.
National Astronaut Day has been celebrated in the US on May 5 since 2016. It commemorates the flight of Alan Shepard, America's first human spaceflight aboard the Freedom 7 Space Capsule. President Trump continues this yearly tradition by issuing a Message on May 5, 2025 declaring:
Sixty-four years ago today, a brave American sat in the cockpit of the Mercury rocket, ready to face the unknown. After years of scientific advancement and growing competition in space exploration, Commander Alan B. Shepard undertook a dangerous mission that held the promise of groundbreaking achievement, national pride, and a future defined by American leadership in space.
With three simple wordslight this candleShepard launched into the vast expanse of space, becoming the first American to break the bounds of Earth. His spacecraft, Freedom 7, was a tribute to the seven Project Mercury astronauts, and to one of our Nations founding principles: freedom.
That same spirit of courage, innovation, and resolve has defined American space exploration ever since. Just 8 years later, Neil Armstrong and Buzz Aldrin planted the Stars and Stripes on the Moon. Last month, we saw the same strength again when I ordered the rescue of stranded astronauts Butch Wilmore and Suni Williams, whose 8-day mission turned into a 286-day journey aboard the International Space Station. It was the vitality of our Nations space programs that rose to the challenge and brought them safely home.
As we celebrate National Astronaut Day, we honor the legacy of those who have blazed the trail into the final frontier. Under my leadership, Americas space program will continue to push the boundaries of discoveries, with bold plans for lunar missions, Mars exploration, and beyond. By fostering innovation, strengthening our partnerships with private space companies, and advancing our technological capabilities, we are ensuring that the United States remains the global leader in space for generations to come.
In 2020,Choo & Rajkumar published a paperacknowledging the shortage of medications during and following the covid debacle. They suggested bringing manufacturing of pharmaceuticals back to the US in order to insure a reliable supply of medication to those who need it. In August 2020, Shuman, Fox, & Unguru wrote a paper calling for action to be taken by pharmacists to anticipate future shortages. By April 2024,Kim, Rothenberger, & Tadrous published a paperon drug shortages from 2017 to 2021 concluding that
. . . continued policy effort is needed to mitigate shortages and to prepare pharmaceutical supply chains for future, unanticipated shocks.
TheFDA keeps a database of drug shortageswhere you can search by generic name or active ingredient to see the current status of availability. The "discontinued" database is even larger than the "shortage" database! You can also search the database by therapeutic categories.
President Trump recognized this issue in 2020; but, his first term ended before he could institute any meaningful change to the situation. But, he did not forget. On May 5, 2025, President Trump signed an EO REGULATORY RELIEF TO PROMOTE DOMESTIC PRODUCTION OF CRITICAL MEDICINESdeclaring:
During my first term, my Administration took unprecedented action to improve the well-being of the American people by restoring capacity for domestic production of critical pharmaceutical products. Notably, in Executive Order 13944 of August 6, 2020 (Combating Public Health Emergencies and Strengthening National Security By Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made In The United States), I directed each executive department and agency involved in the procurement of Essential Medicines, Medical Countermeasures, and Critical Inputs to take a variety of actions to increase their domestic procurement of Essential Medicines, Medical Countermeasures, and Critical Inputs, as defined in section 7 of that order, and to identify vulnerabilities in our Nations supply chains for these products. Unfortunately, the prior administration did too little to advance these goals. Critical barriers and information gaps persist in establishing a domestic, resilient, and affordable pharmaceutical supply chain for American patients.
One key area of concern is the length of time it takes to build pharmaceutical manufacturing facilities in the United States today. New construction must navigate myriad Federal, State, and local requirements ranging from building standards and zoning restrictions to environmental protocols that together diminish the certainty needed to generate investment for large manufacturing projects. For pharmaceutical manufacturing, these barriers are heightened by unannounced inspections of domestic manufacturers by the Food and Drug Administration (FDA), which are more frequent than such inspections at international facilities. Industry estimates suggest that building new manufacturing capacity for pharmaceuticals and critical inputs may take as long as 5 to 10 years, which is unacceptable from a national security standpoint. Even expanding existing capacity or modifying existing production lines to produce new or different products requires extensive permitting and regulatory approval, making it more difficult to repurpose existing underutilized pharmaceutical manufacturing capacity available domestically.
It is in the best interest of the Nation to eliminate regulatory barriers to the domestic production of the medicines Americans need. My Administration will work to make the United States the most competitive nation in the world for the manufacture of safe and effective pharmaceutical products.
Section 2 of the EO states:
It is the policy of the United States that the regulation of manufacturing pharmaceutical products and inputs be streamlined to facilitate the restoration of a robust domestic pharmaceutical manufacturing base.
Sections 3-7 detail how the process will be streamlined, inspected, reviewed, and coordinated. The Fact Sheet provided to accompany the EO elucidates:
PROMOTING AMERICAN-MADE PRESCRIPTION DRUGS: Today, President Donald J. Trump signed an Executive Order to facilitate the restoration of a robust domestic manufacturing base for prescription drugs, including key ingredients and materials necessary to manufacture prescription drugs.
The Order directs the U.S. Food and Drug Administration (FDA) to reduce the amount of time it takes to approve domestic pharmaceutical manufacturing plants by eliminating duplicative and unnecessary requirements, streamlining reviews, and working with domestic manufacturers to provide early support before facilities come online.
The Order directs the FDA to increase fees for and inspections of foreign manufacturing plants.
President Trump is directing the FDA to improve enforcement of active pharmaceutical ingredient source reporting by foreign drug producers and consider publicly displaying a list of facilities that do not comply.
The Order directs the Environmental Protection Agency (EPA) to accelerate the construction of facilities designed to manufacture prescription drugs, active pharmaceutical ingredients, and other necessary raw materials.
The Order ensures that federal agencies issuing permits for a domestic pharmaceutical manufacturing facility designate a single point-of-contact to coordinate permit applications with interagency support from the White House Office of Management and Budget (OMB) to ensure an efficient and coordinated process.
UNLEASHING PROSPERITY AND PROTECTING NATIONAL SECURITY THROUGH PERMITTING REFORM: President Trump is clearing bureaucratic obstacles to critical domestic pharmaceutical manufacturing in order to usher in Americas new Golden Age by ensuring access to the medicines Americans need.
Critical barriers and gaps still exist in establishing a domestic, resilient, and affordable pharmaceutical supply chain for American patients.
New construction must navigate myriad Federal, State, and local requirements ranging from building standards and zoning restrictions to environmental protocols that together diminish the certainty needed to generate investment for large manufacturing projects.
Estimates suggest that building new manufacturing capacity for pharmaceuticals and critical inputs may take as long as five to ten years, which is unacceptable from a national-security standpoint.
This Order will speed up timelines for building domestic pharmaceutical manufacturing site by reducing regulatory barriers to construction.
DELIVERING ON PROMISES TO PUT AMERICA FIRST: President Trump is delivering on his promise to once again put America first by ensuring the FDA prioritizes American manufacturing facilities over foreign facilities.
President Trump: We dont want to be buying our pharmaceuticals from other countries because if were in a war, were in a problem, we want to be able to make our own.
President Trump: As we invest in the future, we will permanently bring our medical supply chains back home. We will produce our medical supplies, pharmaceuticals, and treatments right here in the United States.
This Order builds on actions from President Trumps first term to re-shore production of essential medicines and cut down our reliance on foreign producers.
"Gain of Function (GoF)" became a household term as a result of the covid debacle in 2020. GoF is defined as:
. . . medical research that genetically alters an organism in a way that may enhance the biological functions of gene products. This may include an altered pathogenesis, transmissibility, or host range, i.e., the types of hosts that a microorganism can infect. This research is intended to reveal targets to better predict emerging infectious diseases and to develop vaccines and therapeutics.
Robert F Kennedy Jr explained (see video at the end of this article) that GoF actually began in 1947. By 1973 the US signed the bioweapons charter along with other countries ending GoF. Unfortunately, the 2001 Patriot Act, inSection 1013, violated the bioweapons charter when it re-funded the program. In 2014 NIH paused funding on GoF. In 2017, NIH lifted the funding pause.
The virus possesses a biological characteristic that is not found in nature.
Data shows that all COVID-19 cases stem from a single introduction into humans. This runs contrary to previous pandemics where there were multiple spillover events.
Wuhan is home to Chinas foremost SARS research lab, which has a history of conducting gain-of-function research (gene altering and organism supercharging) at inadequate biosafety levels.
Wuhan Institute of Virology (WIV) researchers were sick with COVID-like symptoms in the fall of 2019, months before COVID-19 was discovered at the wet market.
By nearly all measures of science, if there was evidence of a natural origin it would have already surfaced. But it hasnt.
Multiple Cabinet Secretaries, such as Robert Kennedy, Jr., Tulsi Gabbard, and others in the Trump Administration are working to uncover the whole truth of Covid-19's origins. Secretary Kennedy pointed out that NO labs are immune from leaks and that he cannot point to "any good thing" that has come from GoF research.
Dangerous gain-of-function research on biological agents and pathogens has the potential to significantly endanger the lives of American citizens. If left unrestricted, its effects can include widespread mortality, an impaired public health system, disrupted American livelihoods, and diminished economic and national security.The Biden Administration allowed dangerous gain-of-function research within the United States with insufficient levels of oversight. It also actively approved, through the National Institutes of Health, Federal life-science research funding in China and other countries where there is limited United States oversight or reasonable expectation of biosafety enforcement.This recklessness, if unaddressed, may lead to the proliferation of research on pathogens (and potential pathogens) in settings without adequate safeguards, even after COVID-19 revealed the risk of such practices.
Specifying a change in US policy:
. . . to ensure that United States federally funded research benefits American citizens without jeopardizing our Nations security, strength, or prosperity. My Administration will balance the prevention of catastrophic consequences with maintaining readiness against biological threats and driving global leadership in biotechnology, biological countermeasures, biosecurity, and health research.
And identifying definitions for the purposes of the EO:
dangerous gain-of-function research means scientific research on an infectious agent or toxin with the potential to cause disease by enhancing its pathogenicity or increasing its transmissibility. Covered research activities are those that could result in significant societal consequences and that seek or achieve one or more of the following outcomes:
(a) enhancing the harmful consequences of the agent or toxin;
(b) disrupting beneficial immunological response or the effectiveness of an immunization against the agent or toxin;
(c) conferring to the agent or toxin resistance to clinically or agriculturally useful prophylactic or therapeutic interventions against that agent or toxin or facilitating their ability to evade detection methodologies;
(d) increasing the stability, transmissibility, or the ability to disseminate the agent or toxin;
(e) altering the host range or tropism of the agent or toxin;
(f) enhancing the susceptibility of a human host population to the agent or toxin; or
(g) generating or reconstituting an eradicated or extinct agent or toxin.
PROTECTING AMERICANS FROM DANGEROUS GAIN OF FUNCTION RESEARCH: Today, President Donald J. Trump signed an Executive Order to improve the safety and security of biological research in the United States and around the world. This Executive Order:
Ends any present and all future Federal funding of dangerous gain-of-function research in countries of concern like China and Iran and in foreign nations deemed to have insufficient research oversight.
Empowers American research agencies to identify and end Federal funding of other biological research that could pose a threat to American public health, public safety, or national security.
Prohibits Federal funding from contributing to foreign research likely to cause another pandemic. These measures will drastically reduce the potential for lab-related incidents involving gain-of-function research, like that conducted on bat coronaviruses in China by the EcoHealth Alliance and Wuhan Institute of Virology.
Protects Americans from lab accidents and other biosecurity incidents, such as those that likely caused COVID-19 and the 1977 Russian flu.
ESTABLISHING SAFE AND SECURE OVERSIGHT OF DANGEROUS GAIN OF FUNCTION RESEARCH IN THE UNITED STATES: This Executive Order will increase the safety and security of biological research for Americans without impeding U.S. innovation.
For decades, policies overseeing gain-of-function research on pathogens, toxins, and potential pathogens have lacked adequate enforcement, transparency, and top-down oversight. Researchers have not acknowledged the legitimate potential for societal harms that this kind of research poses.
The Biden Administration allowed dangerous gain-of-function research with insufficient levels of oversight and actively approved Federal life-science research funding in China and other countries.
The 2024 United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential (DURC/PEPP) and the 2024 Framework for Nucleic Acid Synthesis Screening are the latest examples of inadequate policies that rely on self-reporting and fail to protect Americans from dangerous research practices.
This Order pauses research using infectious pathogens and toxins in the United States that may pose a danger to American citizens until a safer, more enforceable, and transparent policy governing such research can be developed and implemented. It directs the Director of the Office of Science and Technology Policy (OSTP) and the National Security Advisor (NSA) to work with funding agencies to develop such a policy within 120 days.
Unlike previous policies, this Order contains enforcement and reporting mechanisms that will strengthen oversight and discourage subjective interpretation of policies that researchers have used in the past to evade biosafety and biosecurity oversight.
SAFEGUARDING THE FUTURE AND PROMOTING AMERICAN BIOTECHNOLOGY DOMINANCE: President Trump is driving us into the Golden Age of American Innovation that will lead us to a safer, healthier, and more prosperous America.
This Order protects Americans from dangerous gain-of-function research that manipulates viruses and other biological agents and toxins, but it does not impede productive biological research that will ensure the United States maintains readiness against biological threats and continues to drive global leadership in biotechnology, biosecurity, and health research.
President Trump has long theorized that COVID-19 originated from a lab leak at the Wuhan Institute of Virology and has consistently pushed for transparency in investigating its origins.
Clandestine on X offers the idea:
I am 99% sure that Trump addressing gain-of-function, is part of the negotiations with Russia.
For years now, Russia have been trying to start a formal UN investigation into US bioweapon production. Russia claim its one of their main reasons for moving into Ukraine in 2022.
Russia have been telling the world that they want justice for Covid. Putin wants Faucis head, along with a great deal of others, to include; Soros, Obama, Clinton, Biden, Bill Gates, and many more, that Russian MIL claim to be involved in US-funded bioweapon development in Ukraine. Those names are not something I made up. All of this information was formally alleged at the UN by Russian MIL, multiple times since 2022. The chart pictured below is part of the formal allegations sent to the UN by Russian MIL. Whether or not you believe Russia is a different conversation, but they actually accused those people of bioweapon production.
Putin will not withdraw his troops unless he has guarantees that US bioweapon development in Ukraine and elsewhere will be stopped, investigated, and are no longer a threat to his People. Theres simply no way this subject did not come up during negotiations. This has been one of Russias main subjects at the UN for 3 years now. Theres no way Trump and Putin did not discuss this.
Trumps EO about gain-of-function tells me that negotiations with Russia went well, and in all likelihood, stopping and investigating gain-of-function is one of the stipulations Putin demanded in order to withdraw, and Trump was happy to cooperate.
Those are some of the exact words used by Googles censors, aka 'Orwelliancontent police,' in describing many of our controversial stories.Stories later proven to be truthful and light years ahead of the mainstream media. But because we reported those 'inconvenient truths' they're trying to bankrupt ANP.
